Procter & Gamble (NYSE:PG) Stock Rating Lowered by Argus

Procter & Gamble (NYSE:PG) was downgraded by analysts at Argus from a “buy” rating to a “hold” rating in a research note issued to investors on Friday, Marketbeat.com reports.

PG has been the subject of several other reports. Royal Bank Of Canada decreased their price objective on Procter & Gamble from $172.00 to $167.00 and set an “outperform” rating for the company in a research report on Thursday, April 9th. BMO Capital Markets raised their target price on shares of Procter & Gamble from $169.00 to $170.00 and gave the stock an “outperform” rating in a report on Monday, June 29th. Bank of America reduced their price target on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a report on Friday, July 10th. Rothschild & Co Redburn lowered their price objective on shares of Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating for the company in a research report on Monday, April 27th. Finally, Wells Fargo & Company raised their price objective on shares of Procter & Gamble from $158.00 to $164.00 and gave the stock an “overweight” rating in a report on Monday, April 27th. Thirteen research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $161.52.

Procter & Gamble Price Performance

Shares of PG stock opened at $146.78 on Friday. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.43. Procter & Gamble has a 12-month low of $137.62 and a 12-month high of $167.25. The firm has a fifty day moving average of $147.81 and a 200-day moving average of $149.00. The firm has a market capitalization of $341.80 billion, a price-to-earnings ratio of 22.17, a price-to-earnings-growth ratio of 4.51 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last posted its earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.02. The firm had revenue of $21.20 billion during the quarter, compared to analysts’ expectations of $21.38 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%.The company’s revenue was up 1.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.48 earnings per share. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, equities research analysts forecast that Procter & Gamble will post 6.99 earnings per share for the current year.

Hedge Funds Weigh In On Procter & Gamble

Several hedge funds have recently made changes to their positions in PG. Capital Financial Group Inc. Co. ADV bought a new stake in shares of Procter & Gamble in the second quarter worth $311,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Procter & Gamble in the second quarter valued at $1,480,650,000. Beverly Hills Private Wealth LLC bought a new position in Procter & Gamble in the second quarter valued at $266,000. OneDigital Investment Advisors LLC acquired a new stake in Procter & Gamble in the 2nd quarter valued at $22,211,000. Finally, Plato Investment Management Ltd bought a new stake in Procter & Gamble during the 2nd quarter worth about $10,010,000. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.